CKS2 and hepatocellular carcinoma: In hepatocellular carcinoma, silencing CKS2 can significantly inhibit the proliferation, migration and invasion of cancer cells, induce the cell cycle to stop in G1 phase, and increase the apoptosis induced by common chemotherapy drugs (27).